Literature DB >> 21130577

Soluble parasite antigens from Babesia canis do not directly activate the kallikrein system in dogs infected with Babesia canis.

A-L Finizio1, J A G M Kleuskens, J Van De Crommert, A Gorenflot, B Carcy, Th P M Schetters.   

Abstract

Soluble parasite antigens (SPA) from Babesia canis have been shown to induce protective immunity when used as vaccine. In order to explain the immune mechanisms of vaccination, the precise role of SPA in the pathogenesis of canine babesiosis is under investigation. Earlier studies suggested that the plasma kallikrein system is central in the pathogenesis of babesiosis, malaria and trypanosomosis, and significant plasma kallikrein activation during acute B. bovis and P. knowlesi infections has been described. In the studies presented here dogs were experimentally infected with B. canis to investigate whether the plasma kallikrein system is activated during babesiosis infection. Results showed that prekallikrein levels decreased during episodes of peak parasitaemia. No effect was found on the kallikrein levels. In order to determine whether B. canis SPA could activate plasma kallikrein, dogs were infused with variable amounts of B. canis SPA and plasma samples were taken for (pre-) kallikrein determination. The results indicated that B. canis SPA did not affect plasma (pre-) kallikrein levels. In addition, the effect of B. canis SPA on (pre-) kallikrein levels in normal dog plasma was determined in vitro. Again, no effect on (pre-) kallikrein levels was found. The results suggest that, although the kallikrein pathway may be involved in B. canis-associated pathology, the system is not directly activated by B. canis SPA. Furthermore, infusion of B. canis SPA as well as stroma of normal dog erythrocytes triggered the production of the acute phase reactant, C-reactive protein. This suggests that the inflammatory response that is triggered during B. canis infection could be in part due to the release and exposure of self molecules. The implications of these findings are discussed.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130577     DOI: 10.1016/j.vetpar.2010.11.005

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  Human babesiosis: Indication of a molecular mimicry between thrombospondin domains from a novel Babesia microti BmP53 protein and host platelets molecules.

Authors:  Ahmed Abdelmoniem Mousa; Daniel Barry Roche; Mohamad Alaa Terkawi; Kyohko Kameyama; Ketsarin Kamyingkird; Patrick Vudriko; Akram Salama; Shinuo Cao; Sahar Orabi; Hanem Khalifa; Mohamed Ahmed; Mabrouk Attia; Ahmed Elkirdasy; Yoshifumi Nishikawa; Xuenan Xuan; Emmanuel Cornillot
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

Review 2.  Mechanisms Involved in the Persistence of Babesia canis Infection in Dogs.

Authors:  Theo Schetters
Journal:  Pathogens       Date:  2019-06-29

3.  LC-MS/MS analysis of the dog serum phosphoproteome reveals novel and conserved phosphorylation sites: Phosphoprotein patterns in babesiosis caused by Babesia canis, a case study.

Authors:  Asier Galán; Anita Horvatić; Josipa Kuleš; Petra Bilić; Jelena Gotić; Vladimir Mrljak
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.